1 (Methylprednisolone Acetate Injectable Suspension N 1)
Methylprednisolone Acetate Injection, Suspension
Product Images NDC 70121-1552
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Acetate (NDC 70121-1552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
1 (Methylprednisolone Acetate Injectable Suspension N 2)
Novaplus™ is a registered trademark of Vizient Inc.*
1 (Methylprednisolone Acetate Injectable Suspension N 3)
This is a medication which should be administered through intramuscular or intrasynovial injection, as indicated for soft tissue use only. MethyIPREDNISolone should not be used intravenously. There is a manufacturing license number provided, along with distribution information. There is additional prescribing information available, and the vial should be shaken before use. The expiration and lot numbers are printed in an unvarnished area of the vial.*
2 (Methylprednisolone Acetate Injectable Suspension N 4)
This is a description of a medication called MethylPREDNISolone N MethylPREDNISolone Acetate Injectable Suspension, USP, distributed by Amneal Pharmaceuticals LLC. It contains 80mg/mL of mettypredrisolone and is intended for intramuscular, intrasynovial, and soft tissue injection only. The medication is not for intravenous use and is provided in a 1 mL single-dose vial that should be stored at 20°C to 25°C. The accompanying prescribing information should be consulted before use.*
3 (Methylprednisolone Acetate Injectable Suspension N 5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
